Antidote Health, formerly Med&Beyond, is a B2C company providing uninsured and underinsured Americans with a virtual HMO via Artificial Intelligence that connects users to doctors with a smart chatbot and through video calls.
Antidote Health uses a telehealth subscription to digitally connect uninsured members with physicians.
Antidote was co-founded in Israel in 2020 by Avihai Soudri, Carine-Belle Feder, David Zlotnick, and Ben Enosh. The company is headquartered in New York and Tel Aviv, Israel.
Antidote launched a 24/7 virtual acute and primary care service across New York, New Jersey, Florida, Michigan, and North Carolina as of January 2021. Antidote plans to rollout to more states continuing through 2022, offering quality healthcare services that are affordable for individuals and families.
Antidote combines state of the art technology with great human experience is the result of a solid technological foundation comprised of AI and machine learning tools and decades of emergency care experience.
Antidote's disruptive technology streamlines patient screening and augments the doctor decision-making process, removing the burden of administrative tasks from the doctor and enhancing the quality of the doctor-patient experience.
Antidote is backed by iAngels, Group 11, Flint Capital, Well-Tech Ventures, and others. The company raised $22M in a Series A round on Mar 22, 2022. This brings Antidote's total funding to $35M to date.